| |
|
|
|
ADMA Biologics Inc.  
|
|
5.01 -0.14 (-0.03%) |
11-19 16:00 |
|
Open: |
5.12 |
Pre close: |
5.15 |
Target:
|
6.29
|
|
High: |
5.19 |
Low: |
4.97 |
Resistance:
|
5.38
5.93
|
|
Volume: |
71,197 |
Market Cap: |
232M |
Support:
|
4.50
3.74
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.06
 |
MACD |
MACD(12,26):
|
-0.17 |
|
MA(20): |
5.36 |
Signal(12,26,9): |
-0.14 |
|
MA(100): |
5.65  |
Stochastic Oscillator |
%K(14,3):
|
16.49 |
|
MA(250): |
4.78 |
%D(3): |
17.53 |
|
Average Volume(K) |
3-Month: |
19576
|
52-Week |
High:
|
6.96 |
|
10-Days: |
12145 |
Low: |
2.42 |
|
RSI |
RSI(14):
|
38.56 |
Change(%): |
72.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.270 |
Return on Equity (ttm) |
-241.8 |
Shares Out. (M) |
46.35 |
|
EPS Est. Current Year |
-1.740 |
Return on Assets (ttm) |
-67.8 |
Shares Float (M) |
46.12 |
|
EPS Est. Next Year |
-1.080 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.50 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
-10.6 |
% Held by Institutions |
70.80 |
|
Forward EPS |
-0.390 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
5.140 |
EBITDA (p.s.) |
0.000 |
P/E |
-3.94 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.97 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-57.24 |
P/S |
400368128.00 |
|
Operating Margin |
-210.73 |
Levered Free Cash Flow
(M) |
-38.67 |
P/CF |
-4.06 |
|
|
|
|
|
|
